Non-specific inhibitors of nitric oxide synthase cause myocardial necrosis in the rat

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 5, 1997, Pages 349-352

  Moreno Jr , Heitor ^a,c   Nathan, Luciana P ^a   Metze, Konradin ^a   Costa, Soraia K P ^a   Antunes, Edson ^a   Hyslop, Stephen ^a   Zatz, Roberto ^b   De Nucci, Gilberto ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

arterial hypertension; coronary flow; ischaemic cardiopathy; myocardial infarctions; N( ) nitro L arginine methyl ester; syndrome X

Indexed keywords

N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; ENZYME INHIBITION; ENZYME SPECIFICITY; HEART MUSCLE NECROSIS; INHIBITION KINETICS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 8244226651     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01200.x     Document Type: Article

References (16)

1. Motz W, Vogt M, Rabenau O, Scheler S, Lückhoff A, Strauer BE. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary arteriograms. Am. J. Cardiol. 1991; 68: 996-1003.
2. Dean JD, Jones CJH, Hutchison SJ, Peters JR, Henderson AH. Hyperinsulinaemia and microvascular angina ('syndrome X'). Lancet 1991; 337: 456-7.
3. Mealy B. Endothelial cell dysfunction: An emerging endocrinopathy linked to coronary disease. J. Am. Coll. Cardiol. 1990; 16: 357-8.
4. Vrints CJM, Built H, Hitter E, Herman AG, Snocck JP. Impaired endothelium-dependent cholinergic coronary vasodilation in patients with angina and normal coronary arteriograms. J. Am. Coll. Cardiol. 1992; 19: 21-31.
5. Rosemhlatt A, Selzer A. The nature and clinical features of myocardial infarction with normal coronary arteriograms. Circulation 1977; 55: 578-80.
6. Ciraulo DA, Bresnahan GF, Frankel PS, Isely PE, Zimmerman W, Chesne RB. Transmural myocardial infarction with normal coronary angiograms and with single vessel coronary obstruction. Clinical-angiographic features and five-year follow-up. Chest 1983; 83: 137-41.
7. Amrani M, O'Shea J, Allen NJ et al. Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J. Physiol. 1992; 456: 681-7.
8. Moreno H Jr, Metze K, Bento AC, Antunes E, Zatz R, de Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res. Cardiol. 1996; 91: 248-55.
9. Factor SM, Bhan R, Minase T, Wolinsky H, Sonnenblick E. Hypertensive-diabetic cardiopathy in the rat. Am. J. Pathol. 1981; 102: 219-28.
10. Ribeiro MO, Antunes E, Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension 1992; 20: 298-304.
11. Langendorff O. Untersuchungen an uberlebeden Saugethierherzen. Pflügers Arch. 1895; 16: 291-382.
12. Neely JR, Leibermeister H, Battersby E, Morgan HE. Effect of pressure development on oxygen consumption by isolated rat hearts. Am. J. Physiol. 1967; 212: 804-14.
13. Zatz R. A low cost tail-cuff method for the estimation of mean arterial pressure in conscious rats. Lab. Anim. Sci. 1990; 40: 198-201.
14. Huckslorf C, Zanzinger J, Fink B, Bassenge E. Reduced nitric oxide formation causes coronary vasoconstriction and impaired dilator responses to endogenous agonists and hypoxia in dogs. Arch. Pharmacol. 1994; 349: 367-73.
15. Weber KT, Brilla CG, Janicki JS. Signals for the remodeling of the cardiac interstitium in systemic hypertension. J. Cardiovasc. Pharmacol. 1991; 17(Suppl. 2): 14.
16. Moreno H Jr, Nathan LP, Costa SKP et al. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide. Eur. J. Pharmacol. 1995; 287: 93-6.